Efficacy and safety of intermittent hemodialysis using citrate as anticoagulant: a prospective study
Clicks: 187
ID: 273472
2007
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
4.5
/100
15 views
15 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Intermittent hemodialysis with citrate anticoagulation can be safely applied in critically ill patients at high risk of bleeding.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (18 words).
Try re-searching for a better abstract.
| Reference Key |
m2007clinicalefficacy
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Schneider M;Thomas K;Liefeldt L;Kindgen-Milles D;Peters H;Neumayer HH;Morgera S;; |
| Journal | clinical nephrology |
| Year | 2007 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
female
male
middle aged
Prospective Studies
Clinical Trial
calcium / metabolism
hemodynamics / drug effects
renal dialysis / adverse effects*
blood coagulation / drug effects
electrolytes
pmid:18044262
doi:10.5414/cnp68302
m schneider
k thomas
s morgera
acid-base equilibrium / drug effects
anticoagulants / adverse effects*
anticoagulants / pharmacology
citric acid / adverse effects*
citric acid / pharmacology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.